Madrigal Pharmaceuticals (MDGL) PT Lowered to $962 at Barclays

July 31, 2026 6:12 AM

Barclays analyst Eliana Merle lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $962.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found